VP, GPL Franchise Lead – HCT; Hematology and Cell Therapy

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:

VP, GPL Franchise Lead – HCT (Hematology and Cell Therapy)

Accountable for maximizing the value of the HCT portfolio by shaping the end-to-end disease strategy, in partnership with Research, Development, Global Product Development & Supply (GPS), and Commercialization, and leading a team of Global Program Leads to translate those strategies into efficient execution. This role reports to the SVP, Head of HCT Development with matrix reporting to the SVP, Drug Development Strategy & Portfolio Management.

• Set the end-to-end disease strategy spanning the full lifecycle in partnership with drug development functions (including Strategy & Portfolio Management, global regulatory & safety, and global development operations), and other functions (including research, commercialization, GPS, and enterprise strategy).
• Accelerate the portfolio and reduce development timelines for most promising new assets, while optimizing the revenue and reach of currently marketed products.
• Lead all R&D business development activities for the Immunology and Cardiovascular portfolio, in partnership with the Business Development team and DD Strategy & Portfolio Management.
• Effectively manage disease portfolio budget, making trade‑off decisions with an enterprise mindset.

• Leads and inspires a high‑performing organization of Global Program Leaders (GPLs) across the Disease Area.
• Oversees orchestration of design and execution of globally integrated program strategies, timelines, and budgets from candidate nomination to successful launch, commercialization, and lifecycle management within Hematology and Cell Therapy.
• Prioritizes, synthesizes, and pressure tests feedback from senior leadership on program direction/outputs and coaches GPLs in building this skillset.
• Provides strategic and technical leadership to build a world‑class drug development team while enabling the balance between scientific excellence and operational effectiveness.
• Demonstrates inspirational leadership to engage, develop, and create an inclusive/diverse environment that drives innovation.
• Demonstrates superior enterprise mindset and leadership maturity to shape the future of R&D.
• Ensures Program Leaders within the Disease Area demonstrate must‑win capabilities and partner effectively with functions within R&D (e.g., Clinical Development) and across the Enterprise (e.g., Operations, GPS, Commercial).
• Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans under the remit.
• Clearly communicates program risks, implications of changes in the competitive landscape, and progress toward key milestones.
• Leads team problem‑solving in delivering key data and interpretation essential for robust debate and rapid, data‑driven decision making.
• Leverages experience to efficiently integrate information from team members and facilitate rapid and objective, data‑driven decisions.
• Leads team members to effectively engage cross‑company expertise and utilize governance bodies to define asset development strategies and implementation plans.